- Report
- September 2026
- 193 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 194 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 189 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 181 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 183 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 199 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 197 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 187 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 186 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 187 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 196 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 195 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 199 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 185 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 188 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 194 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 181 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 189 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 187 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP
- Report
- September 2026
- 195 Pages
Global
From €3272EUR$3,545USD£2,739GBP
€3635EUR$3,939USD£3,044GBP

The Antimicrobial Resistance Surveillance (ARS) market is a subset of the Diagnostics industry, focused on the detection and monitoring of antimicrobial resistance. ARS involves the collection and analysis of data on the prevalence of antimicrobial resistance in a population, as well as the identification of the genetic elements responsible for the resistance. This data is used to inform public health policy and to guide the development of new treatments and strategies to combat antimicrobial resistance. ARS is a rapidly growing market, driven by the increasing prevalence of antimicrobial resistance and the need for better surveillance and monitoring.
Companies in the ARS market include bioMérieux, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more